The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
treatment of patients with aorto-iliac occlusion,stenosis, or aneurysm
CHU La Miletrie, 350 av. Jacques Coeur
86021 Poitiers, France
RECRUITINGGraft patency at three years
Time frame: three years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.